Epidemiological evidence has demonstrated that the increase of cognitive impairment is worldwide problem. 1,2 Hypertension has been reported as one of the most important risk factors for cognitive impairment; not only has only higher blood pressure (BP) been associated with diminished cognitive function, but also a direct robust association between hypertension and the risk of stroke, and thus, of post-stroke dementia, has been established. 3 Twenty-four-hour BP level assessed by ambulatory BP monitoring (ABPM) has more predictive power for cardiovascular outcomes compared with clinic BP measurement, 4 and BP variability evaluated by ABPM has also been associated with target organ damage and cardiovascular outcome independent of ambulatory BP level. 5 However, previous studies of the relationship between BP variability assessed by ABPM and cognitive impairment show some inconsistencies. [6] [7] [8] [9] [10] To clarify this association, an investigation of a population with well ambulatory BP control is needed because BP variability is strongly dependent on the average BP level. 11 Several cognitive tests have been recognized to be efficient in detecting cognitive symptoms; however, the widely used Mini-Mental State Examination (MMSE) does not test domains related to executive function. 12 Executive function is one of the most important domains of cognitive function impaired by hypertension. 12 The Montreal Cognitive Assessment (MoCA) has consistently been proven to be higher than that of the MMSE, especially for detecting milder cognitive symptoms, 13 because it includes very sensitive tasks for the evaluation of executive function. Although some studies have reported an association between ambulatory BP variability and cognitive function assessed by MMSE, 6, [8] [9] [10] the data of the association using MoCA is sparse. 7 The aim of this study was to test the hypothesis that BP variability using ABPM would be associated with cognitive 
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METHODS

Patients
This study is a substudy of the Japan Ambulatory Blood Pressure Prospective (JAMP) study, which is a nationwide prospective observational study of Japanese patients with one or more cardiovascular risk factors that aims to evaluate regional differences in BP control status assessed by ABPM and its effect on cardiovascular events in different areas around Japan. All patients in this study were enrolled from Minamisanriku hospital located in Tohoku, in the northeast region of Honshu, Japanups main island, where the tsunami occurring from the Great East Japan Earthquake on March 11, 2011 , destroyed approximately 60% of the residential area and wiped out all medical resources. After the earthquake, a webbased BP monitoring system (the Disaster CArdiocascular Prevention [DCAP] Network) was introduced to help control survivors' BPs using home BP monitoring and automatically transmitting their data to a central computer database and to the respective attending physicians. 14 This system helped achieve a decrease in the participants' self-measured home BP from 151.3 ± 20.0/86.9 ± 10.2 mm Hg on May 2011 to 120.2 ± 12.1/70.8 ± 10.2 mm Hg on June 2015. 15 The institutional review board of the Jichi Medical University School of Medicine approved this study, and written informed consent was obtained from all participants.
ABPM and other measurements
ABPM was carried out with a validated automatic device (TM 2431, A&D, Saitama, Japan) that recorded the participant's BP using an oscillometric method together with the participant's pulse rate every 30 minutes for 24 hours. All data were taken in July 2016. We used the weighted SD of systolic BP (SBP) as the index of BP variability, defined as the mean of day and night SD values corrected for the number of hours included in each of these periods. 16 In the present study, the body mass index was calculated as weight (kg)/height (m 2 ). Current smoking was defined as smoking at the time of study enrollment or within the prior year. Diabetes was defined as having a fasting glucose level ≥126 mg/dl and/or a glycated hemoglobin level ≥6.5% (in National Glycohemoglobin Standardization Program units) or being treated with one or more antidiabetic medications. Hyperlipidemia was defined as having a total cholesterol level ≥240 mg/dl or being treated with one or more antihyperlipidemic medications. A history of cardiovascular disease was defined as having had one or more of the following: angina pectoris, myocardial infarction, heart failure, aortic dissection, or stroke.
Cognitive assessment
We used the Japanese version of MoCA (MoCA-J) as a cognitive screening tool. The diagnostic accuracy of MoCA-J has been reported to be almost the same that of the original version of MoCA for both mild cognitive impairment and Alzheimer's disease. 17 MoCA-J scores range from 0 to 30, and can be broken into seven MoCA-J subscores including Visuoexecutive, Naming, Attention, Language, Abstraction, Recall, and Orientation. 18 
Statistical analysis
Data are means ± SDs and percentages. All statistical analyses were carried out with SPSS statistics software, version 19 (IBM, Chicago, IL). The univariate association between age and MoCA-J score was assessed using Spearman's correlation, because we subjected the MoCA-J scores to an analysis of skewness and used the Shapiro-Wilk test for the significance of skew, and the Shapiro-Wilk statistic suggested a data set with significant skew (P = 0.002). One-way analysis of variance was performed to detect differences among groups while Tukey's honestly significant differences test was used for multiple pairwise comparisons of the means among groups. Analysis of covariance was performed to detect differences among groups after adjustment for covariates, and the Bonferroni test was used for comparisons. Multiple linear regression analysis was performed to estimate and test the independent effects of BP indices on the MoCA-J score and the domain subset score of MoCA-J. Two-tailed P values <0.05 were considered statistically significant.
RESULTS
Patient's characteristics
A total of 232 participants were enrolled in this study. The baseline characteristics of the subjects are shown in Table 1 . The age range was from 52 to 95 years. The prevalence of patients over 65 years old was 91.8%. Most of patients were treated by antihypertensive medication. The use of calcium channel blockers and angiotensin II receptor antagonists was high. The average 24-hour BP were 118.7 ± 10.0/68.3 ± 6.4 mm Hg. The average 24-hour BP level in this group showed good control (<130/80 mm Hg), at a prevalence of 87.1%. The average total MoCA-J score was 17.3 ± 6.0. Figure 1 shows the distribution of the MoCA-J score.
Association between MoCA-J and characteristics of patients
Age was strongly correlated with total MoCA-J score (r = −0.62, P < 0.001). Therefore, after adjustment by age, we investigated the association between the MoCA-J score and possible confounding factors (Table 2 ). There were no significant differences in MoCA-J scores for gender, body mass index (< or ≥25 kg/m 2 ), smoking, diabetes, hyperlipidemia, use of antihypertensive drug, and past history of CVD. Likewise, no differences in MoCA-J were found between those using or not using each class of antihypertensive drug (Supplementary Table S1 ).
When we divided the patients into quartiles of 24-hour SBP (quartile 1, ≤111.3 mm Hg; quartile 2, 111.4-118.4 mm Hg; quartile 3, 118.5-124.6 mm Hg; and quartile 4, ≥124.7 mm Hg), there were no significant differences in MoCA-J scores among the 4 groups (quartile 1, 16.6 ± 5.3; quartile 2, 17.7 ± 7.1; quartile 3, 17.5 ± 5.9; and quartile 4, 17.4 ± 5.6; P trend, 0.789). This association was similar after adjustment by age and weighted SD of SBP (Figure 2 ). When we divided the patients into quartiles of weighted SD of SBP (quartile 1, ≤14.0 mm Hg; quartile 2, 14.1-16.9 mm Hg; quartile 3, 17.0-19.5 mm Hg; and quartile 4, ≥19.6 mm Hg), there were significant differences in MoCA-J scores among the 4 groups (quartile 1, 18.9 ± 6.5; quartile 2, 19.2 ± 5.1; quartile 3, 17.0 ± 5.5; and quartile 4, 14.1 ± 5.6; P trend <0.001). The quartile 4 group had a significantly lower MoCA-J score than each other group (vs. quartile 1, P < 0.001; vs. quartile 2, P < 0.001; vs. quartile 3, P = 0.037). After adjustment by age and 24-hour SBP, quartile 4 of weighted SD of BP had a lower MoCA-J score compared with the quartile 1 and 2 groups (Figure 2) . The results of a multiple linear regression analysis showed that the weighted SD of SBP was independently associated with the total MoCA-J score adjusted by age and 24-hour SBP (standardized β = −0.16, P = 0.004).
Concerning the association between the domain subset score of MoCA-J and 24-hour SBP, when we combined quartiles 1 through 3 and compared their mean scores with those of quartile 4, there were no significant differences between quartiles 1-3 and quartile 4 after adjustment for age, except for the subscore of Abstraction (Table 3) . Concerning the association between the domain subset score of MoCA-J and the weighted SD of SBP, quartile 4 was significantly lower in the total score of MoCA-J and the subscores of Visuoexecutive, Abstraction, Attention, and Naming than the combined group of the quartiles 1-3 (Table 3 ). Supplementary Table S2 shows the adjusted association of 24-hour SBP and the weighted SD of SBP with the MoCA-J domain subset score in the multiple regression analysis. There was no association between 24-hour SBP and the MoCA-J domain subset score except for the subscore of abstraction (standardized β= 0.14, P = 0.023), whereas there was an association between the weighted SD of SBP and the subscores of attention (standardized β = −0.17, P = 0.008) and naming (standardized β = −0.15, P = 0.024).
DISCUSSION
This study demonstrated that exaggerated 24-hour BP variability using ABPM was associated with cognitive impairment assessed by MoCA-J in the Japanese population who achieved well BP control. In addition, after dividing the patients into quartiles by the 24-hour BP variability, patients with highest quartile had lower scores in specific domains of MoCA-J, namely, Visuoexective, Abstraction, Attention, and Naming, whereas these associations were not found in the quartiles of 24-hour SBP.
This study showed that increased weighted SD was associated with cognitive impairment assessed by MoCA-J. Weighted SD has been recently developed to assess short-term BP variability over 24 hours, because it excluded the effect of nocturnal BP dipping and was associated with target organ damage or cardiovascular outcome more than conventional 24-hour BP variability. 16 The most notable result in this study was that in patients with well BP control, higher BP variability assessed by ABPM was associated with cognitive impairment. The relationship between BP variability assessed by ABPM and cognitive function remains controversial. Some previous studies have shown that large BP variability assessed by ABPM is associated with cognitive impairment. 7-9 Sakakura et al. reported that SD of daytime SBP in ABPM was incrementally associated with cognitive impairment assessed by MMSE when a population age 61 years and up combining younger elderly (aged 61 to 79 years) with very elderly patients (≥80 years) was divided by SD into tertiles. 9 Kanemaru et al. investigated the association between cognitive function according to the Hasegawa Dementia Scale Revised test (HDSR), MMSE, and the Raven's Coloured Progressive Matrices Test and BP variability in 88 subjects (mean age, 71 ± 9 years) with no history of stroke. 8 In that study, subjects who had cognitive impairment showed higher SD of daytime BP in ABPM compared with those of normal cognitive function. 8 On the other hand, there was one report in which BP variability was not associated with cognitive impairment. 7 Coneway et al. reported no association between 24-hour SBP, average real variability in ABPM and cognitive impairment for MoCA obtained from 319 Western community-living older adults. 7 Importantly, the present study differs from previous studies in terms of its population's 24-hour average BP level. Compared with the BP in our study, 119 ± 10/68 ± 6 mm Hg, all of the previous studies had higher average 24-hour BP levels: Sakakura et al. 9 131 ± 13/76 ± 6 mm Hg in younger elderly and 138 ± 18/76 ± 8 mm Hg in very elderly; Kanemaru et al. 8 142 ± 15 mm Hg; Coneway et al. 7 127 ± 13/73 ± 8 mm Hg. Our findings suggest that BP variability was associated with cognitive function even under well BP control. Increased BP variability, not only BP level, might provide the possibility of the progression of cognitive impairment. This study found that weighted SD was associated with some subsets in the MoCA-J (Visuoexective, Attention Abstraction, and Naming), but not others (Recall, Language, and Orientation). MoCA was developed as a more challenging test that includes executive function, higher-level language, and complex visuospatial processing to enable detection of mild impairment with less ceiling effect. 13 Greater sensitivity at detecting mild levels of cognitive Values are means (95% confidence intervals) after adjustment by age. Abbreviations: BMI, body mass index; CVD, cardiovascular disease; MoCA-J, Japanese version of the Montreal Cognitive Assessment.
impairment has been reported for the MoCA in a population with mild cognitive impairment. 19 Therefore, our result suggest that in well BP control, increased BP variability might initially aggravate some of domain, such as Visuoexective, Abstraction, Attention, and Naming, which may result in the progression of cognitive impairment.
To the best of our knowledge, there is no previous study about the relationship between BP variability assessed by ABPM and the various domains of MoCA. Kim et al. reported that SBP variability assessed by ABPM was associated with reduced attention, frontal executive dysfunction, and visuospatial dysfunction tested by another cognitive function test, the Seoul Neuropsychological Screening Battery 20 ; however, it has not been confirmed that the test is consistent with the results of MoCA.
It is not clear why increased BP variability would be associated with specific domains of cognitive impairment (Visuoexective, Attention, Abstraction, and Naming). Zhao et al. reported that 25 patients with stenosis or occlusion of cerebral artery had lower scores than the control group in only some MoCA domains (Visuoexective, Attention, Abstraction, and Recall). 21 In that study, computed tomography perfusion imaging found abnormal perfusion in 21 of 25 patients at the anterior cerebral artery area or the cortex and the deep perforating branch of the middle cerebral artery. 21 Another study reported that ischemic hyperintensive lesions in both the gray matter (thalamus and caudate) supplied by the middle cerebral artery and the white matter supplied by the anterior or middle cerebral artery was associated with impaired cognitive function involving executive function. 22 Thus, a sudden decrease in BP caused by exaggerated BP variability might lead to ischemia to the cerebral area supplied by the anterior and middle cerebral artery, resulting in impairments in the specific cognitive functions evaluated by MoCA.
In this study, there was no association between 24-hour SBP level and cognitive impairment. The association between BP level and cognition from cross-sectional studies has been controversial. Some studies have suggested that high BP is associated with worse cognitive function while other studies have reported the opposite association or no association. [23] [24] [25] [26] However, in those studies BP was measured by clinic BP. There has been only one study about the association between 24-hour SBP level and cognitive function assessed by MoCA. 7 Coneway et al. reported a lack of association between 24-hour SBP level and MoCA, 7 consistent with our findings. Recently, the Systolic Blood Pressure Intervention Trial (SPRINT), which included the oldest old, showed that strict SBP control (<120 mm Hg) reduced the main cardiovascular events compared with standard SBP control (<140 mm Hg). 27 The extensive data on brain health of that study, SPRINT Memory and Cognition in Decreased Hypertension (SPRINT-MIND) supports the hypothesis that strict BP control could reduce the risk of stroke and help preserve cognition. 28 This study has some limitations. First, our findings cannot be generalized to other populations of outpatients, because this study was performed at a single center at which a single physician controlled BP in this population. Second, this study was performed during the summer. Some researchers have reported that BP levels assessed by ABPM during the summer were well controlled compared to the winter. 29, 30 Therefore, is this study would be performed in any other season, the change in season may yield different findings. Third, the causal relationship between BP variability and cognitive impairment is unclear because this study is a cross-sectional study. Fourth, about 80% of participants in this study use one or more antihypertensive drugs. We cannot exclude the influence of antihypertensive drugs for BP variability.
In conclusion, higher BP variability, not average ambulatory BP level, was associated with cognitive impairment in elderly patients with well ambulatory BP control.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of Hypertension online. 
